BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21905514)

  • 1. Fixed drug eruption due to meloxicam.
    Ozdemir SK; Erkekol FO; Aydin O; Celik GE; Misirligil Z
    J Investig Allergol Clin Immunol; 2011; 21(5):419-20. PubMed ID: 21905514
    [No Abstract]   [Full Text] [Related]  

  • 2. [Meloxicam: intramuscular administration in rheumatology].
    Tsvetkova ES
    Ter Arkh; 2003; 75(8):96-7. PubMed ID: 14520864
    [No Abstract]   [Full Text] [Related]  

  • 3. [Efficacy and intolerance of meloxicam in injection and tablet form].
    Tiurin VP; Rakov AL
    Voen Med Zh; 2003 Nov; 324(11):54-8. PubMed ID: 14725079
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and tolerability of meloxicam in an observational, controlled cohort study in patients with rheumatic disease.
    Degner F; Sigmund R; Zeidler H
    Clin Ther; 2000 Apr; 22(4):400-10. PubMed ID: 10823362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meloxicam tolerance in hypersensitivity to nonsteroidal anti-inflammatory drugs.
    Domingo MV; Marchuet MJ; Culla MT; Joanpere RS; Guadaño EM
    J Investig Allergol Clin Immunol; 2006; 16(6):364-6. PubMed ID: 17153884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of meloxicam in patients with aspirin/non-steroidal anti-inflammatory drug-induced urticaria and angioedema.
    Göksel O; Aydin O; Misirligil Z; Demirel YS; Bavbek S
    J Dermatol; 2010 Nov; 37(11):973-9. PubMed ID: 21039786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rheumatic disease therapy without regret. Meloxicam dosage safety].
    MMW Fortschr Med; 2002 Nov; 144(46):66-7. PubMed ID: 12534086
    [No Abstract]   [Full Text] [Related]  

  • 8. Cutaneous and ocular adverse reactions in a dog following meloxicam administration.
    Niza MM; Félix N; Vilela CL; Peleteiro MC; Ferreira AJ
    Vet Dermatol; 2007 Feb; 18(1):45-9. PubMed ID: 17222240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of subsyde-CR versus meloxicam in rheumatic disorders.
    Patel BR
    J Indian Med Assoc; 2000 May; 98(5):250-2. PubMed ID: 11002624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-pigmenting cutaneous-mucosal fixed drug eruption due to piroxicam.
    Montoro J; Díaz M; Genís C; Lozano A; Bertomeu F
    Allergol Immunopathol (Madr); 2003; 31(1):53-5. PubMed ID: 12573211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticosteroid cross-reactivity.
    Isaksson M; Bruze M
    Contact Dermatitis; 2003 Jul; 49(1):53-4. PubMed ID: 14641133
    [No Abstract]   [Full Text] [Related]  

  • 12. [Meloxicam--the balance of efficacy and safety].
    Morović-Vergles J
    Reumatizam; 2008; 55(2):85-6. PubMed ID: 19024285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-sensitivity to multiple topical corticosteroids.
    Goh CL
    Contact Dermatitis; 1989 Jan; 20(1):65-7. PubMed ID: 2521595
    [No Abstract]   [Full Text] [Related]  

  • 14. Meloxicam: a review of its pharmacokinetics, efficacy and tolerability following intramuscular administration.
    Euller-Ziegler L; Vélicitat P; Bluhmki E; Türck D; Scheuerer S; Combe B
    Inflamm Res; 2001 Mar; 50 Suppl 1():S5-9. PubMed ID: 11339521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical drug-induced acute generalized exanthematous pustulosis misdiagnosed as an oral drug-related eruption.
    Cubero JL; Garcés MM; Segura N; Sobrevía MT; Fraj J; Lezaun A; Colás C
    J Investig Allergol Clin Immunol; 2010; 20(7):620-1. PubMed ID: 21314006
    [No Abstract]   [Full Text] [Related]  

  • 16. [Methotrexate in conjunction with meloxicam for treating ankylosing spondylitis: a clinical observation of the efficacy and safety].
    Xie RL; Li XH; Kang XT
    Di Yi Jun Yi Da Xue Xue Bao; 2003 May; 23(5):460-2. PubMed ID: 12754130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergy to corticosteroids: update and review of epidemiology, clinical characteristics, and structural cross-reactivity.
    Scheuer E; Warshaw E
    Am J Contact Dermat; 2003 Dec; 14(4):179-87. PubMed ID: 14738718
    [No Abstract]   [Full Text] [Related]  

  • 18. Ischaemic colitis in a patient taking meloxicam.
    Garcia B; Ramaholimihaso F; Diebold MD; Cadiot G; Thiéfin G
    Lancet; 2001 Mar; 357(9257):690. PubMed ID: 11247558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerability of meloxicam in patients with histories of adverse reactions to nonsteroidal anti-inflammatory drugs.
    Quaratino D; Romano A; Di Fonso M; Papa G; Perrone MR; D'Ambrosio FP; Venuti A
    Ann Allergy Asthma Immunol; 2000 Jun; 84(6):613-7. PubMed ID: 10875490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An unusual case of penile non-pigmenting fixed drug eruption in a child.
    Keli-Bhija Z; de Blic J; Ponvert C
    Pediatr Allergy Immunol; 2015 May; 26(3):294-296. PubMed ID: 25712503
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.